173 related articles for article (PubMed ID: 23625390)
1. Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis.
Jaros JA; Guest PC; Bahn S; Martins-de-Souza D
Methods Mol Biol; 2013; 1002():1-11. PubMed ID: 23625390
[TBL] [Abstract][Full Text] [Related]
2. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
Zolotarjova N; Mrozinski P; Chen H; Martosella J
J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
[TBL] [Abstract][Full Text] [Related]
3. 2D DIGE analysis of serum after fractionation by ProteoMiner™ beads.
Liang C; Tan GS; Chung MC
Methods Mol Biol; 2012; 854():181-94. PubMed ID: 22311761
[TBL] [Abstract][Full Text] [Related]
4. In-depth analysis of a plasma or serum proteome using a 4D protein profiling method.
Tang HY; Beer LA; Speicher DW
Methods Mol Biol; 2011; 728():47-67. PubMed ID: 21468940
[TBL] [Abstract][Full Text] [Related]
5. Abundant plasma protein depletion using ammonium sulfate precipitation and Protein A affinity chromatography.
Pringels L; Broeckx V; Boonen K; Landuyt B; Schoofs L
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():43-59. PubMed ID: 29758408
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of affinity ligands for depletion of abundant plasma proteins.
Kullolli M; Warren J; Arampatzidou M; Pitteri SJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():10-6. PubMed ID: 24090752
[TBL] [Abstract][Full Text] [Related]
7. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
Faca V; Pitteri SJ; Newcomb L; Glukhova V; Phanstiel D; Krasnoselsky A; Zhang Q; Struthers J; Wang H; Eng J; Fitzgibbon M; McIntosh M; Hanash S
J Proteome Res; 2007 Sep; 6(9):3558-65. PubMed ID: 17696519
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional separation of human plasma proteins using iterative free-flow electrophoresis.
Nissum M; Kuhfuss S; Hauptmann M; Obermaier C; Sukop U; Wildgruber R; Weber G; Eckerskorn C; Malmström J
Proteomics; 2007 Dec; 7(23):4218-27. PubMed ID: 17973290
[TBL] [Abstract][Full Text] [Related]
9. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
[TBL] [Abstract][Full Text] [Related]
10. Avoiding nonspecific interactions in studies of the plasma proteome: practical solutions to prevention of nonspecific interactions for label-free detection of low-abundance plasma proteins.
Richens JL; Lunt EA; Sanger D; McKenzie G; O'Shea P
J Proteome Res; 2009 Nov; 8(11):5103-10. PubMed ID: 19817376
[TBL] [Abstract][Full Text] [Related]
11. An alternative method for serum protein depletion/enrichment by precipitation at mildly acidic pH values and low ionic strength.
Henning AK; Albrecht D; Riedel K; Mettenleiter TC; Karger A
Proteomics; 2015 Jun; 15(11):1935-40. PubMed ID: 25644273
[TBL] [Abstract][Full Text] [Related]
12. Combination of highly efficient hexapeptide ligand library-based sample preparation with 2D DIGE for the analysis of the hidden human serum/plasma proteome.
Hartwig S; Lehr S
Methods Mol Biol; 2012; 854():169-80. PubMed ID: 22311760
[TBL] [Abstract][Full Text] [Related]
13. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
Percy AJ; Chambers AG; Yang J; Borchers CH
Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
[TBL] [Abstract][Full Text] [Related]
14. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
Ndao M
Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
[TBL] [Abstract][Full Text] [Related]
15. Comparative 2D DIGE analysis of the depleted serum proteome for biomarker discovery.
Penno M; Ernst M; Hoffmann P
Methods Mol Biol; 2012; 854():207-20. PubMed ID: 22311763
[TBL] [Abstract][Full Text] [Related]
16. A proteome signature for intrauterine growth restriction derived from multifactorial analysis of mass spectrometry-based cord blood serum profiling.
Wölter M; Röwer C; Koy C; Reimer T; Rath W; Pecks U; Glocker MO
Electrophoresis; 2012 Jul; 33(12):1881-93. PubMed ID: 22740482
[TBL] [Abstract][Full Text] [Related]
17. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome.
Pieper R; Su Q; Gatlin CL; Huang ST; Anderson NL; Steiner S
Proteomics; 2003 Apr; 3(4):422-32. PubMed ID: 12687610
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
[TBL] [Abstract][Full Text] [Related]
19. FTMS and TOF/TOF mass spectrometry in concert: identifying peptides with high reliability using matrix prespotted MALDI target plates.
Dekker LJ; Burgers PC; Guzel C; Luider TM
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):62-4. PubMed ID: 16963321
[TBL] [Abstract][Full Text] [Related]
20. The human plasma proteome: analysis of Chinese serum using shotgun strategy.
He P; He HZ; Dai J; Wang Y; Sheng QH; Zhou LP; Zhang ZS; Sun YL; Liu F; Wang K; Zhang JS; Wang HX; Song ZM; Zhang HR; Zeng R; Zhao X
Proteomics; 2005 Aug; 5(13):3442-53. PubMed ID: 16047309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
